Hiromi Matsumoto

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 01, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.

Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi

|Nov 14, 2023
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

Nobuaki Kobayashi, Kenji Miura, Ayami Kaneko

|Sep 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita

Pageof 1

Frequent Collaborators

3 joint publications

Nobuaki Kobayashi

1 joint publications

Nobuyuki Horita

1 joint publications

Nobuhiko Fukuda

1 joint publications

Shuhei Teranishi